Dates: 01/01/2021
31/12/2025
Topic: Biomarkers identification
AI/Big data
Project type: Preclinic
Theranostic
Project target: Cancer
Financing:
H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC)
Participating agents:
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Keywords: Prostate cancer; colorectal cancer; drug resistance; reinforcement; tumour; biomarker; HTS; QSAR; monotherapy
Countries: Germany
Project page: Access page
